Analystreport

Vistagen Therapeutics Inc (NASDAQ: VTGN) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.

VistaGen Therapeutics, Inc.  (VTGN) 
Last vistagen therapeutics, inc. earnings: 2/13 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.vistagen.com